Hospital Sirio-Libanes, Serviços Médicos de Anestesia Ltda, São Paulo, SP, Brazil.
Massachusetts General Hospital, Harvard Medical School, Department of Anaesthesia, Critical Care and Pain Medicine, Boston, USA.
Braz J Anesthesiol. 2021 Jul-Aug;71(4):326-332. doi: 10.1016/j.bjane.2021.03.006. Epub 2021 Apr 15.
The prevalence of Substance Use Disorders (SUD) and acceptance of drug testing among anesthetists in Brazil has not been determined.
An internet-based survey was performed to investigate the prevalence of SUD among anesthetists in Brazil, to explore the attitudes of anesthetists regarding whether SUD jeopardizes the health of an impaired provider or their patient, and to determine the provider's perspective regarding acceptance and effectiveness of drug testing to reduce SUD. The questionnaire was distributed via social media. REDCap was utilized to capture data. A sample size of 350 to achieve a confidence level of 95% and confidence interval of 5 was estimated. Study report was based on STROBE and CHERRIES statements.
The survey was returned from 1,295 individuals. Most individuals knew an anesthesia provider with a SUD (82.07%), while 23% admitted personal use. The most common identified substances of abuse were opioids (67.05%). Very few respondents worked in a setting that performs drug testing (n = 17, 1.33%). Most individuals believed that drug testing could improve personal safety (82.83%) or the safety of patients (85.41%). Individuals with a personal history of SUD were less likely to believe in the effectiveness of drug testing to reduce one's own risk (74.92% vs. 85.18%, p < 0.0001) or improve the safety of patients (76.27% vs. 88.13%, p < 0.001).
SUDs are common among anesthetists in Brazil. Drug testing would be accepted as a viable means to reduce the incidence although a larger study should be performed to investigate the logistical feasibility.
在巴西，尚未确定麻醉师中物质使用障碍（SUD）的流行程度以及对药物检测的接受程度。
我们进行了一项基于互联网的调查，以调查巴西麻醉师中 SUD 的流行程度，探讨麻醉师对 SUD 是否会危及受损提供者或其患者健康的态度，以及确定提供者对药物检测减少 SUD 的接受程度和有效性的看法。该问卷通过社交媒体分发。使用 REDCap 捕获数据。估计样本量为 350，以达到 95%的置信水平和 5%的置信区间。研究报告基于 STROBE 和 CHERRIES 声明。
该调查共收到 1295 人的回复。大多数人认识一位有 SUD 的麻醉师（82.07%），而 23%的人承认自己有个人用药史。最常见的滥用物质是阿片类药物（67.05%）。很少有受访者在进行药物检测的环境中工作（n=17，1.33%）。大多数人认为药物检测可以提高个人安全性（82.83%）或患者安全性（85.41%）。有 SUD 个人史的个体不太相信药物检测可以降低自身风险（74.92%比 85.18%，p<0.0001）或提高患者安全性（76.27%比 88.13%，p<0.001）。
在巴西，麻醉师中 SUD 很常见。尽管应该进行更大规模的研究来调查后勤可行性，但药物检测将被接受为减少发病率的可行手段。
